Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glargine Dosing in Renal Insufficiency
NCT00911625Phase 4Completed
- Sponsor
- Loyola University Chicago
- Start
- Jan 2009
- Primary completion
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine in type 2 diabetes mellitus (T2DM), sponsored by Loyola University Chicago. Started Jan 2009; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00911625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00911625.